Prev：ELISA based assays to measure adenosine deaminases concentration in serum and saliva for the diagnosis of ADA2 deficiency and cancer(A21000-9)
Next：Elucidating the role of CYFIP2 in conferring cisplatin resistance in esophageal squamous cell carcinoma(ABL1010-3.9)
